about
Affinity and avidity in antibody-based tumor targetingTherapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studiesProtein engineering and its applications in food industry.The role and mechanism of exogenous calcitonin gene-related peptide on mesenchymal stem cell proliferation and osteogenetic formation.Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cellsThe internally truncated LRP5 receptor presents a therapeutic target in breast cancerA tool kit for rapid cloning and expression of recombinant antibodies.Monocytes and macrophages in cancer: development and functionsIntratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.Immune therapies for neuroblastoma.Anti-GD2 antibody therapy for GD2-expressing tumors.Novel antibody-based proteins for cancer immunotherapy.Immunological Aspects of Malignant Gliomas.Motif-programmed artificial protein induces apoptosis in several cancer cells by disrupting mitochondria.Antibody fragment expression and purification.Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields.Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients.Nanotechnology in retinal drug delivery.
P2860
Q24613552-929F0484-3B9F-49DC-829D-66D9F7F704E5Q26781698-9BF84ED9-54D5-4E21-B48F-A9E836BF695FQ30375542-22211FD1-A6BA-4FD0-9883-466132A95F43Q31151877-EF33F35E-CD1B-4C5E-94DA-C7A16AB500F5Q33301319-B4C3400E-3638-4C47-B562-FDF3536475ECQ33401589-424B721D-B4BF-41AA-94BA-281361DD5A44Q33970343-07927058-4EB9-49F4-8272-D972E804E77BQ37028772-A3D16B6D-0F20-41BB-82DA-FF7E4D508AB3Q37322304-DBB2BDEE-B5BB-44B8-A371-4BA3C431FAB2Q37431356-1B96FBCC-9D19-496E-B121-F4E03C17FB81Q37702283-023C6E86-530B-4103-98A6-B10B50B3BF45Q38161370-C49D89E2-6CC5-49E1-A72A-CF490E7901FCQ38870994-DE260DD2-1EBB-45A7-B5CF-7773AE47C5FEQ40013679-1A63120F-0D98-4AF0-9D1F-F53766A42CC1Q40156939-959D6946-DFAC-4296-8C08-90B5721AF181Q41673094-74F79367-DD22-41D0-8E00-CBD702A10E4BQ46627677-E4D1FFC2-DEC0-4FE0-9E60-F9C8DF211C0CQ55491207-76BA0235-4093-44E5-B984-9F75371AB480
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Novel antibodies as anticancer agents.
@en
type
label
Novel antibodies as anticancer agents.
@en
prefLabel
Novel antibodies as anticancer agents.
@en
P2093
P2860
P356
P1433
P1476
Novel antibodies as anticancer agents.
@en
P2093
Michaeli Y
Zafir-Lavie I
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210372
P407
P577
2007-05-01T00:00:00Z
P5875
P6179
1004962367